Studies have demonstrated greater BACE1 activity and protein concentration in Alzheimer’s disease compared with elderly health controls and patients with mild cognitive impairment compared to controls or Alzheimer’s disease patients. This evidence concerns the gene BACE1 and Cognitive impairment.